A detailed history of Northeast Investment Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Northeast Investment Management holds 86,796 shares of TMO stock, worth $48.6 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
86,796
Previous 86,954 0.18%
Holding current value
$48.6 Million
Previous $48.1 Million 11.65%
% of portfolio
2.46%
Previous 2.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$531.86 - $624.21 $84,033 - $98,625
-158 Reduced 0.18%
86,796 $53.7 Million
Q2 2024

Jul 26, 2024

SELL
$541.52 - $599.02 $253,431 - $280,341
-468 Reduced 0.54%
86,954 $48.1 Million
Q1 2024

May 01, 2024

SELL
$528.82 - $599.43 $482,283 - $546,680
-912 Reduced 1.03%
87,422 $50.8 Million
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $288,613 - $356,536
-669 Reduced 0.75%
88,334 $46.9 Million
Q3 2023

Nov 08, 2023

SELL
$498.29 - $574.41 $208,285 - $240,103
-418 Reduced 0.47%
89,003 $45.1 Million
Q2 2023

Jul 28, 2023

SELL
$508.46 - $591.13 $1.01 Million - $1.17 Million
-1,985 Reduced 2.17%
89,421 $46.7 Million
Q1 2023

Apr 28, 2023

SELL
$535.0 - $604.82 $1.22 Million - $1.38 Million
-2,289 Reduced 2.44%
91,406 $52.7 Million
Q4 2022

Jan 27, 2023

SELL
$484.71 - $571.37 $882,172 - $1.04 Million
-1,820 Reduced 1.91%
93,695 $51.6 Million
Q3 2022

Oct 28, 2022

SELL
$507.19 - $604.49 $626,886 - $747,149
-1,236 Reduced 1.28%
95,515 $48.4 Million
Q2 2022

Aug 05, 2022

SELL
$500.9 - $612.21 $989,277 - $1.21 Million
-1,975 Reduced 2.0%
96,751 $52.6 Million
Q1 2022

May 04, 2022

SELL
$524.0 - $644.92 $1.18 Million - $1.45 Million
-2,253 Reduced 2.23%
98,726 $58.3 Million
Q4 2021

Feb 07, 2022

SELL
$569.0 - $667.24 $1.4 Million - $1.64 Million
-2,464 Reduced 2.38%
100,979 $67.4 Million
Q3 2021

Nov 08, 2021

SELL
$509.53 - $609.78 $1.49 Million - $1.78 Million
-2,916 Reduced 2.74%
103,443 $59.1 Million
Q2 2021

Aug 05, 2021

SELL
$441.0 - $508.24 $1.51 Million - $1.74 Million
-3,415 Reduced 3.11%
106,359 $53.7 Million
Q1 2021

May 11, 2021

SELL
$439.85 - $518.83 $1.32 Million - $1.55 Million
-2,994 Reduced 2.66%
109,774 $50.1 Million
Q4 2020

Feb 10, 2021

SELL
$435.06 - $527.66 $1.97 Million - $2.39 Million
-4,531 Reduced 3.86%
112,768 $52.5 Million
Q3 2020

Nov 13, 2020

BUY
$359.77 - $441.52 $139,590 - $171,309
388 Added 0.33%
117,299 $51.8 Million
Q2 2020

Aug 11, 2020

BUY
$275.2 - $362.34 $90,816 - $119,572
330 Added 0.28%
116,911 $42.4 Million
Q1 2020

May 13, 2020

SELL
$255.3 - $340.05 $473,836 - $631,132
-1,856 Reduced 1.57%
116,581 $33.1 Million
Q4 2019

Feb 12, 2020

SELL
$271.93 - $328.04 $351,061 - $423,499
-1,291 Reduced 1.08%
118,437 $38.5 Million
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $241,613 - $274,887
-900 Reduced 0.75%
119,728 $34.9 Million
Q2 2019

Aug 12, 2019

SELL
$257.51 - $295.55 $167,639 - $192,403
-651 Reduced 0.54%
120,628 $35.4 Million
Q1 2019

May 14, 2019

BUY
$212.17 - $273.72 $87,414 - $112,772
412 Added 0.34%
121,279 $33.2 Million
Q4 2018

Feb 13, 2019

SELL
$208.47 - $251.98 $366,281 - $442,728
-1,757 Reduced 1.43%
120,867 $27 Million
Q3 2018

Nov 13, 2018

SELL
$205.57 - $244.32 $157,877 - $187,637
-768 Reduced 0.62%
122,624 $29.9 Million
Q2 2018

Aug 13, 2018

BUY
$203.14 - $219.53 $575,495 - $621,928
2,833 Added 2.35%
123,392 $25.6 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $70,437 - $81,800
365 Added 0.3%
120,559 $24.9 Million
Q4 2017

Jan 29, 2018

BUY
$182.03 - $200.37 $811,307 - $893,049
4,457 Added 3.85%
120,194 $22.8 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $19.9 Million - $22.5 Million
115,737
115,737 $21.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $219B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Northeast Investment Management Portfolio

Follow Northeast Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.